UVA Pulmonologist Unleashes Precision Medicine to Combat Pulmonary Fibrosis
Imre Noth, MD, helped secure $22 million in NIH and private funding to dramatically alter how idiopathic pulmonary fibrosis (IPF) is diagnosed and treated.
UVA Pulmonology Takes National Lead in Understanding Pandemic’s Toll
UVA pulmonologists established one of the nation's first post-COVID clinics and brings valuable insights into COVID’s longterm toll by tying clinical data to blood biomarkers.
Pregnancy and Pulmonary Arterial Hypertension: Patient Choice and Medical Advice Come Together
A case study highlighting the collaborative care required to help one mother survive a complex pregnancy and delivery.
Get to Know: Pulmonologist Imre Noth, MD, MS
Imre Noth, MD, is an expert on interstitial lung diseases with a special emphasis on idiopathic pulmonary fibrosis. He has joined UVA as chief of the Division of Pulmonary and Critical Care Medicine.
UVA Is Improving the Odds for Lung Transplant Patients
Ex Vivo Lung Perfusion extends the period of time lungs can remain viable outside of the body, giving lung recipients access to lungs in locations beyond the region in which they are listed.
Differentiating Among Interstitial Lung Diseases
The UVA Interstitial Lung Disease Program is one of just 40 centers in the U.S. designated as a Pulmonary Fibrosis Foundation Care Network site, which speaks to the level of expertise and quality of care provided, as well as the progress being made at UVA in advancing treatment for these complex lung disorders.
A Medical Home for Challenging Asthma Patients
The Severe Asthma Program continues to grow, with clinical services and research efforts specifically tailored to the needs of pediatric patients.